Prophylix Pharma A/S

Forskningsparken
1902 Tromsø
Norway

Contact

About Prophylix Pharma

Prophylix Pharma AS is a Norwegian company founded in 2008 by a group of scientists, Norinnova Technology Transfer AS and University Hospital of Northern Norway in Tromsø . The company is dedicated to develop a new prophylactic treatment of Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT).

News about Prophylix Pharma

09-May-2012 | business & finance

Consortium lead by Prophylix Pharma AS receives up to €6 M in EU-funding

The EU grant is for development of a prophylactic treatment to prevent severe bleeding and death in newborns caused by Fetal/Neonatal Alloimmune Trombocytopenia

Read news

Show more news about Prophylix Pharma

Here you will find Prophylix Pharma A/S

Last viewed contents

Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine - Establishment of additional lipid production in Germany for use with mRNA-based vaccines

Go to page

Get the life science industry in your inbox

Prophylix Pharma A/S

About Prophylix Pharma

News about Prophylix Pharma

Consortium lead by Prophylix Pharma AS receives up to €6 M in EU-funding

Here you will find Prophylix Pharma A/S

Last viewed contents

Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine - Establishment of additional lipid production in Germany for use with mRNA-based vaccines

Prophylix Pharma A/S